TABLE 2

Use of Non-IVIG Therapy for 4811 Patients With KD

n (%)
Antiinflammatory therapy
    Methylprednisolone278 (5.8)
    Orally administered prednisone and prednisolone133 (2.8)
    Infliximab48 (1.0)
Antithrombotic therapy
    Aspirin4429 (92.1)
    Heparin2004 (41.7)
    Warfarin54 (1.1)
    Enoxaparin49 (1.0)
    Tissue plasminogen activator33 (0.7)
    Clopidogrel16 (0.3)
    Abciximab10 (0.2)